Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Community Health Systems, Inc. (CYH)
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-05
$2.28-4.20%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - Care FacilitiesSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for CYH yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Complete strategic acquisitions to enhance market position | A supporting condition in Community Health Systems, Inc.'s published investment case. The stated target is Complete multiple acquisitions annually. | Intact | No acquisitions completed in next 12 months | 2 acquisitions completed vs 0 trip condition Completed Huntsville Hospital (Apr) and Freeman Health System (Jun) acquisitions; policy headwinds noted but no stalled recovery. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a higher-risk hospital operator with recent operating strength, not a steady earnings compounder. The long-term thesis is intact, but management execution is volatile and earnings quality remains weak because the company is loss-making.
CYH is described as cheap versus peers, while the valuation measure has recently risen and its model confidence is low. The priced-in assessment is marked justified, with no fragility gates triggered, but the negative expectations gap suggests the market is not assuming an easy operating outlook.
Near term, earnings risk is elevated: CYH has missed in recent quarters, including on October 28, and the evidence flags a high chance of another miss. Operating measures have improved, with same-store admissions and revenue growing in 2026-Q3, and operating cash flow was higher than a year earlier, though consolidated revenue was lower. Debt reduction has continued through divestiture proceeds, but quality and experience outcomes are not quantified.
The multi-year view depends on whether improving same-store volumes and revenue can continue while the company manages debt and delivers on service priorities. A guidance cut or further weakening in jobs data would add pressure; continued strong results and higher guidance from sector peers could support the industry backdrop.
Over the next 1 to 3 years, CYH’s thesis rests on sustaining operating improvement and reducing debt despite repeated earnings misses and elevated risk. The evidence is mixed, so execution and the next earnings updates matter. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
EPS improves toward breakeven in FY27 |
| A primary condition in Community Health Systems, Inc.'s published investment case. The stated target is >= $0.10 per share. |
| Broken |
| EPS remains below zero in FY27 |
Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Manage regulatory and litigation risks | A supporting condition in Community Health Systems, Inc.'s published investment case. The stated target is No material adverse rulings or penalties. | Intact | Material adverse regulatory ruling or large penalty announced | No material adverse rulings or penalties reported News cites policy headwinds and CMS rule concerns affecting guidance, but no specific adverse regulatory ruling or penalty is reported. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue near $11.6B in FY26 | A primary condition in Community Health Systems, Inc.'s published investment case. The stated target is ~$11.6B. | Broken | revenue falls below $11B in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.11 → $-0.93 · observed estimates
$11.78B → $11.33B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.11 | $11,782,935,610 | 8 / 7 |
| 2026-07-25 | $0.00 | $11,710,190,990 | 6 / 7 |
| 2026-07-26 | $0.00 | $11,710,190,990 | 6 / 7 |
| 2026-07-27 | $-0.08 | $11,710,190,990 | 7 / 7 |
| 2026-07-28 | $-0.08 | $11,710,190,990 | 7 / 7 |
| 2026-07-29 | $-0.41 | $11,559,756,420 | 7 / 7 |
| 2026-07-30 | $-0.41 | $11,559,756,420 | 7 / 7 |
| 2026-07-31 | $-0.41 | $11,559,756,420 | 7 / 7 |
| 2026-08-01 | $-0.37 | $11,559,756,421 | 3 / 5 |
| 2026-08-02 | $-0.41 | $11,559,756,420 | 7 / 7 |
| 2026-08-03 | $-0.37 | $11,559,756,421 | 4 / 5 |
| 2026-08-04 | $-0.41 | $11,559,756,420 | 7 / 7 |
| 2026-08-05 | $-0.37 | $11,559,756,421 | 4 / 5 |
| 2026-08-06 | $-0.53 | $11,532,184,990 | 7 / 7 |
| 2026-08-07 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-08 | $-0.53 | $11,532,184,990 | 7 / 7 |
| 2026-08-09 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-10 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-11 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-12 | $-0.53 | $11,532,184,990 | 7 / 7 |
| 2026-08-13 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-14 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-15 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-16 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-17 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-18 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-19 | $-0.47 | $11,532,184,992 | 4 / 5 |
| 2026-08-20 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-21 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-22 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-23 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-24 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-25 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-26 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-27 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-28 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-29 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-30 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-08-31 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-01 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-02 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-03 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-04 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-05 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-06 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-07 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-08 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-09 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-10 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-11 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-12 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-13 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-14 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-15 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-16 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-17 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-18 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-19 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-20 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-21 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-22 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-23 | $-0.46 | $11,537,613,564 | 4 / 5 |
| 2026-09-24 | $-0.46 | $11,526,036,868 | 4 / 5 |
| 2026-09-25 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-09-26 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-09-27 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-09-28 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-09-29 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-09-30 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-01 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-02 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-03 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-04 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-05 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-06 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-07 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-08 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-09 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-10 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-11 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-12 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-13 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-14 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-15 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-16 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-17 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-18 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-19 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-20 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-21 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-22 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-23 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-24 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-25 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-26 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-27 | $-0.46 | $11,526,036,868 | 4 / 6 |
| 2026-10-28 | $-0.46 | $11,536,161,868 | 4 / 6 |
| 2026-10-29 | $-0.46 | $11,536,161,868 | 4 / 6 |
| 2026-10-30 | $-0.65 | $11,424,148,743 | 4 / 6 |
| 2026-10-31 | $-0.76 | $11,423,211,085 | 3 / 5 |
| 2026-11-01 | $-0.76 | $11,423,211,085 | 3 / 5 |
| 2026-11-02 | $-0.76 | $11,423,211,085 | 3 / 5 |
| 2026-11-03 | $-0.76 | $11,423,211,085 | 3 / 5 |
| 2026-11-04 | $-0.93 | $11,332,461,085 | 3 / 5 |
| 2026-11-05 | $-0.93 | $11,332,461,085 | 3 / 5 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 5 Hold · 3 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 4 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.